Gritstone Bio Implements Workforce Reduction Following Delay in COVID-19 Vaccine Trial

Gritstone Bio, COVID-19 vaccine trial delay, 40% workforce layoffs, Phase 2b CORAL trial, Manufacturing delay, Missed funding, Project NextGen, BARDA contract, Colorectal cancer vaccine